Bayer Net Income 2006-2021 | BAYRY

Bayer annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Bayer net income for the quarter ending June 30, 2021 was $-2.805B, a 73.32% decline year-over-year.
  • Bayer net income for the twelve months ending June 30, 2021 was $-3.404B, a 44.67% decline year-over-year.
  • Bayer annual net income for 2020 was $-11.988B, a 361.65% decline from 2019.
  • Bayer annual net income for 2019 was $4.582B, a 128.89% increase from 2018.
  • Bayer annual net income for 2018 was $2.002B, a 75.86% decline from 2017.
Bayer Annual Net Income
(Millions of US $)
2020 $-11,988
2019 $4,582
2018 $2,002
2017 $8,292
2016 $5,014
2015 $4,564
2014 $4,554
2013 $4,236
2012 $3,146
2011 $3,443
2010 $1,728
2009 $1,895
2008 $2,529
2007 $6,457
2006 $2,114
2005 $1,989
Bayer Quarterly Net Income
(Millions of US $)
2021-06-30 $-2,805
2021-03-31 $2,518
2020-12-31 $90
2020-09-30 $-3,208
2020-06-30 $-10,513
2020-03-31 $1,643
2019-12-31 $1,566
2019-09-30 $1,152
2019-06-30 $454
2019-03-31 $1,410
2018-12-31 $-4,709
2018-09-30 $3,356
2018-06-30 $953
2018-03-31 $2,402
2017-12-31 $774
2017-09-30 $4,561
2017-06-30 $1,346
2017-03-31 $1,610
2016-12-31 $464
2016-09-30 $1,325
2016-06-30 $1,559
2016-03-31 $1,667
2015-12-31 $707
2015-09-30 $1,111
2015-06-30 $1,274
2015-03-31 $1,471
2014-12-31 $201
2014-09-30 $1,096
2014-06-30 $1,307
2014-03-31 $1,950
2013-12-31 $634
2013-09-30 $971
2013-06-30 $1,098
2013-03-31 $1,532
2012-12-31 $474
2012-09-30 $661
2012-06-30 $635
2012-03-31 $1,377
2011-12-31 $534
2011-09-30 $909
2011-06-30 $1,075
2011-03-31 $935
2010-12-31 $-199
2010-09-30 $361
2010-06-30 $670
2010-03-31 $914
2009-12-31 $219
2009-09-30 $373
2009-06-30 $725
2009-03-31 $556
2008-12-31 $135
2008-09-30 $417
2008-06-30 $908
2008-03-31 $1,141
2007-12-31 $272
2007-09-30 $1,614
2007-06-30 $890
2007-03-31 $3,680
2006-12-31 $417
2006-09-30 $408
2006-06-30 $571
2006-03-31 $718
2005-12-31 $20
2005-09-30 $605
2005-06-30 $520
2005-03-31 $841
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $52.049B $47.287B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $431.227B 17.94
Roche Holding AG (RHHBY) Switzerland $311.243B 0.00
Pfizer (PFE) United States $247.816B 14.08
Novo Nordisk (NVO) Denmark $234.679B 32.57
Eli Lilly (LLY) United States $222.149B 28.85
AbbVie (ABBV) United States $188.027B 9.01
Novartis AG (NVS) Switzerland $185.202B 13.75
Merck (MRK) United States $182.082B 12.47
AstraZeneca (AZN) United Kingdom $181.247B 25.77
Sanofi (SNY) $120.758B 13.30
GlaxoSmithKline (GSK) United Kingdom $104.607B 13.13
H Lundbeck (HLUYY) Denmark $5.375B 10.30
Innoviva (INVA) United States $1.103B 5.92